RADD 54 mg: Each prolonged-release tablet contains 54 mg methylphenidate hydrochloride. Contains sugar (lactose monohydrate 174,00 mg). For the full list of excipients, see section 6.1. Methylphenidate HCl is a mild central nervous system (CNS) stimulant.

Daily dosage above 54 mg is not recommended in children between 6–12 years. Daily dosage above 72 mg is not recommended in adolescents aged 13–18 years. Daily dosage above 108 mg is not recommended in adults. The long-term use of RADD has not been systematically evaluated.

RADD is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children 6 to 17 years of age and in adults aged 18 to 65 who meet DSM-IV criteria for

What RADD is and what it is used for RADD contains methylphenidate hydrochloride, one of a group of medicines called centrally acting sympathomimetics. RADD is used in children over the age of 6 years and adults in the treatment of Attention Deficit Hyperactivity Disorder (ADHD)

2025年1月1日 · Methylphenidate is a central nervous system stimulant. It affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control. Methylphenidate is used to treat attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), and …

2024年9月1日 · Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and ...

In healthy adults, single and multiple dosing of once daily prolonged release methylphenidate doses from 54 to 144 mg/day resulted in linear and dose proportional increases in C max and AUCinf for total methylphenidate (MPH) and its major metabolite, (alpha)-phenyl-piperidine acetic …

2021年6月22日 · Radd 18 mg, 27 mg, 36 mg and 54 mg, Methylphenidate Hydrochloride. Ask your Pharmacist or Doctor for further information. Please LOGIN or REGISTER to view. Our …

Radd PR 54mg tablets are central nervous system stimulants available at Transpharm.

2024年4月2日 · Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and ...